Concepedia

Katherine Fisher

KF

Statistics

Publications

14

Citations

757

H-Index

13

Active since

2002

Affiliations

Pfizer (United States)(Current)

Takeda (United States)

Birkbeck, University of London

Deerfield (United States)

University of Rochester

Katherine Fisher is an author at Pfizer (United States) specializing in medicine, drug discovery, and pharmacology.

ORCID

Top concepts

Publications per year

2002–2022

14

Publications

14

Selective Inhibition of Casein Kinase 1ϵ Minimally Alters Circadian Clock Period

Kevin M. Walton, Katherine Fisher, David M. Rubitski et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 177 citations

An Inhibitor of Casein Kinase Iϵ Induces Phase Delays in Circadian Rhythms under Free-Running and Entrained Conditions

Lori L. Badura, Terri A. Swanson, Wendy O. Adamowicz et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 171 citations

Spirocyclic Sulfamides as β-Secretase 1 (BACE-1) Inhibitors for the Treatment of Alzheimer’s Disease: Utilization of Structure Based Drug Design, WaterMap, and CNS Penetration Studies To Identify Centrally Efficacious Inhibitors

Michael A. Brodney, Gabriela Barreiro, Kevin Ogilvie et al. · Journal of Medicinal Chemistry · 2012 · 60 citations · Full text

, , +20

The 5-Hydroxytryptamine4 Receptor Agonists Prucalopride and PRX-03140 Increase Acetylcholine and Histamine Levels in the Rat Prefrontal Cortex and the Power of Stimulated Hippocampal θ Oscillations

David E. Johnson, Elena M. Drummond, Sarah Grimwood et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 57 citations

Expression of rat I-TAC/CXCL11/SCYA11 during central nervous system inflammation: comparison with other CXCR3 ligands

Shaun R. McColl, Maria Staykova, Laurie Tylaska et al. · Laboratory Investigation · 2004 · 50 citations · Full text

, , +13

1–5 of 14